Collectively, elevated expression of both ORAI1 and ORAI3 underpins cancer hallmarks across diverse tumor types, positioning them as prognostic indicators and actionable therapeutic targets in malignancies, including lung cancer. Here, ORAI1 is linked to neoplasm.